Cargando…
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Met...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415222/ https://www.ncbi.nlm.nih.gov/pubmed/37576806 http://dx.doi.org/10.3389/fphar.2023.1192855 |
_version_ | 1785087480888819712 |
---|---|
author | Tang, Zhen-Chu Qu, Qiang Teng, Xin-Qi Zhuang, Hai-Hui Xu, Wei-Xin Qu, Jian |
author_facet | Tang, Zhen-Chu Qu, Qiang Teng, Xin-Qi Zhuang, Hai-Hui Xu, Wei-Xin Qu, Jian |
author_sort | Tang, Zhen-Chu |
collection | PubMed |
description | Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Methods: Literature published before Dec 31, 2022, in WOSCC, was systematically classified, and Citespace, bibliometric.com/app, and GraphPad Prism analyzed the data. Results: After screening out inappropriate documents and duplicate data, 911 publications were selected for further bibliometric analysis. The top five research areas were Oncology (257, 28.211%), Cell Biology (210, 23.052%), Biochemistry Molecular Biology (209, 22.942%), Science Technology Other Topics (138, 15.148%), and Genetics Heredity (132, 14.490%). The United States of America (United States) has the highest number of documents (462, 50.71%), followed by China (303, 33.26%). Among the most productive institutions, four of which are from the United States and one from Singapore, the National University of Singapore. Harvard Medical School (7.68%) has the highest percentage of articles. Young, Richard A, with 32 publications, ranks first in the number of articles. The top three authors came from Whitehead Institute for Biomedical Research as a research team. More than two-thirds of the research are supported by the National Institutes of Health of the United States (337, 37.654%) and the United States Department of Health Human Services (337, 37.654%). And “super enhancer” (525), “cell identity” (258), “expression” (223), “cancer” (205), and “transcription factor” (193) account for the top 5 occurrence keywords. Discussion: Since 2013, SE and cancer related publications have shown a rapid growth trend. The United States continues to play a leading role in this field, as the top literature numbers, affiliations, funding agencies, and authors were all from the United States, followed by China and European countries. A high degree of active cooperation is evident among a multitude of countries. The role of SEs in cell identity, gene transcription, expression, and inhibition, as well as the relationship between SEs and TFs, and the selective inhibition of SEs, have received much attention, suggesting that they are hot issues for research. |
format | Online Article Text |
id | pubmed-10415222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104152222023-08-12 Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer Tang, Zhen-Chu Qu, Qiang Teng, Xin-Qi Zhuang, Hai-Hui Xu, Wei-Xin Qu, Jian Front Pharmacol Pharmacology Introduction: In the past decade, super-enhancer (SE) has become a research hotspot with increasing attention on cancer occurrence, development, and prognosis. To illustrate the hotspots of SE in cancer research and its evolutionary tendency, bibliometric analysis was carried out for this topic. Methods: Literature published before Dec 31, 2022, in WOSCC, was systematically classified, and Citespace, bibliometric.com/app, and GraphPad Prism analyzed the data. Results: After screening out inappropriate documents and duplicate data, 911 publications were selected for further bibliometric analysis. The top five research areas were Oncology (257, 28.211%), Cell Biology (210, 23.052%), Biochemistry Molecular Biology (209, 22.942%), Science Technology Other Topics (138, 15.148%), and Genetics Heredity (132, 14.490%). The United States of America (United States) has the highest number of documents (462, 50.71%), followed by China (303, 33.26%). Among the most productive institutions, four of which are from the United States and one from Singapore, the National University of Singapore. Harvard Medical School (7.68%) has the highest percentage of articles. Young, Richard A, with 32 publications, ranks first in the number of articles. The top three authors came from Whitehead Institute for Biomedical Research as a research team. More than two-thirds of the research are supported by the National Institutes of Health of the United States (337, 37.654%) and the United States Department of Health Human Services (337, 37.654%). And “super enhancer” (525), “cell identity” (258), “expression” (223), “cancer” (205), and “transcription factor” (193) account for the top 5 occurrence keywords. Discussion: Since 2013, SE and cancer related publications have shown a rapid growth trend. The United States continues to play a leading role in this field, as the top literature numbers, affiliations, funding agencies, and authors were all from the United States, followed by China and European countries. A high degree of active cooperation is evident among a multitude of countries. The role of SEs in cell identity, gene transcription, expression, and inhibition, as well as the relationship between SEs and TFs, and the selective inhibition of SEs, have received much attention, suggesting that they are hot issues for research. Frontiers Media S.A. 2023-07-27 /pmc/articles/PMC10415222/ /pubmed/37576806 http://dx.doi.org/10.3389/fphar.2023.1192855 Text en Copyright © 2023 Tang, Qu, Teng, Zhuang, Xu and Qu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Tang, Zhen-Chu Qu, Qiang Teng, Xin-Qi Zhuang, Hai-Hui Xu, Wei-Xin Qu, Jian Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title | Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title_full | Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title_fullStr | Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title_full_unstemmed | Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title_short | Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
title_sort | bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415222/ https://www.ncbi.nlm.nih.gov/pubmed/37576806 http://dx.doi.org/10.3389/fphar.2023.1192855 |
work_keys_str_mv | AT tangzhenchu bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer AT quqiang bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer AT tengxinqi bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer AT zhuanghaihui bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer AT xuweixin bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer AT qujian bibliometricanalysisofevolutionarytrendsandhotspotsofsuperenhancersincancer |